維百奧生物特約代理Avidity Biosciences公司產(chǎn)品。
Avidity Biosciences公司位于美國加州La Jolla,是一家專門從事抗體寡核苷酸結(jié)合物(AOC?)技術(shù)開發(fā)的生物技術(shù)公司,此項(xiàng)技術(shù)結(jié)合了單抗組織選擇性和寡核苷酸療法的精確性,克服了寡核苷酸給藥屏障。
Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC?). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.
Antibody oligonucleotide conjugate (AOC?) technology
Avidity’s antibody oligonucleotide conjugate (AOC?) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.
維百奧(北京)生物科技有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!
維百奧生物